title: Erratum to: nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial.
authors.affiliation: Centre hospitalier de l'université de Montréal (CHUM), Montreal, QC, Canada. mustapha.tehfe.chum@ssss.gouv.qc.ca.
authors.forename: Mustapha
authors.initials: M
authors.lastname: Tehfe
authors.affiliation: Tom Baker Cancer Centre, Calgary, AB, Canada.
authors.forename: Scot
authors.initials: S
authors.lastname: Dowden
authors.affiliation: British Columbia Cancer Agency, Vancouver, BC, Canada.
authors.forename: Hagen
authors.initials: H
authors.lastname: Kennecke
authors.affiliation: Royal Victoria Regional Health Centre, Barrie, ON, Canada.
authors.forename: Robert
authors.initials: R
authors.lastname: El-Maraghi
authors.affiliation: Hôpital du Sacré-Coeur de Montreal, Montreal, QC, Canada.
authors.forename: Bernard
authors.initials: B
authors.lastname: Lesperance
authors.affiliation: Centre hospitalier universitaire de Québec (CHUQ), Hôtel-Dieu de Quebec, CHUM, Montreal, QC, Canada.
authors.forename: Felix
authors.initials: F
authors.lastname: Couture
authors.affiliation: Centre hospitalier de l'université de Montréal (CHUM), Montreal, QC, Canada.
authors.forename: Richard
authors.initials: R
authors.lastname: Letourneau
authors.affiliation: Celgene Corporation, Summit, NJ, USA.
authors.forename: Helen
authors.initials: H
authors.lastname: Liu
authors.affiliation: Celgene Corporation, Summit, NJ, USA.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Romano